| Results From Argos Therapeutics' Arcelis™ Immunotherapy Phase 2 Study for ... - PR-USA.net (press release) |
|
|
PR-USA.net (press release)Argos Therapeutics today announced that results from its Arcelis™ immunotherapy Phase 2 study for the treatment of renal cell carcinoma (RCC) have been ... read more |